Social Factors Associated with the Risk of Glaucoma Suspect Conversion to Glaucoma: Analysis of the Nationwide All of Us Program

Overview

Journal Ophthalmol Glaucoma

Date 2024 Jul 3

PMID 38959998

Authors

Jo-Hsuan Wu

Willam Halfpenny

Jennifer Bu

Manreet Brar

Robert N Weinreb

Sally L Baxter

Affiliations

Soon will be listed here.

Abstract

Purpose: To examine social factors associated with the 5-year risk of glaucoma suspects (GS) converting to open-angle glaucoma (OAG).

Design: Retrospective cohort analysis.

Subjects: We screened for participants diagnosed with GS in the All of Us database. Cases that converted to OAG within 5 years of GS diagnosis (the "conversion group") were compared with control cases that did not convert.

Methods: Demographic, socioeconomic and health-care utilization data of the cases were extracted and compared between the conversion group and the control group. Multivariable Cox proportional hazards modeling was used to identify potential factors associated with the risk of conversion.

Main Outcome Measures: Hazard ratios (HRs) of significant factors associated with the risk of conversion.

Results: A total of 5274 GS participants were identified, and 786 (15%) cases converted to OAG within 5-year follow-up. The 2 groups showed significant differences in age, race, gender, employment status, income/education level, history of intraocular surgery, and health-care utilization patterns. In the multivariable model, African American/Black race (HR : 1.70 [95% confidence interval (CI), 1.44-2.00]), older age at GS diagnosis (1.17 [95% CI, 1.09-1.25]), male gender (1.30 [95% CI, 1.13-1.50], no history of recreational drug use (1.23 [1.07-1.42]), history of intraocular surgery (1.60 [95% CI, 1.02-1.53]), and having more reasons for delayed health-care access (2.27 [95% CI, 1.23-4.18]) were associated with a greater hazard of conversion, while being employed (0.71 [95% CI, 0.60-0.86]) was associated with a smaller hazard of conversion (P < 0.05 for all).

Conclusions: Several social factors were associated with the conversion from GS to OAG, which may help to identify patients at higher risk of disease progression. Future studies are needed to examine the basis for these findings and the potential interventions that could address them.

Financial Disclosures: Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.

References

Leshno A, Shukla A, Liebmann J . Is it Time to Revisit Glaucoma Suspect Nomenclature?. Ophthalmol Glaucoma. 2024; 7(3):219-221. DOI: 10.1016/j.ogla.2024.02.003. View

Wu J, Varkhedi V, Radha Saseendrakumar B, Acuff K, Weinreb R, Baxter S . Social and Health Care Utilization Factors Associated With Ophthalmic Visit Nonadherence in Glaucoma: An All of Us Study. J Glaucoma. 2023; 32(12):1029-1037. PMC: 10840877. DOI: 10.1097/IJG.0000000000002300. View

Vajaranant T, Nayak S, Wilensky J, Joslin C . Gender and glaucoma: what we know and what we need to know. Curr Opin Ophthalmol. 2010; 21(2):91-9. PMC: 4326058. DOI: 10.1097/ICU.0b013e3283360b7e. View

Chang R, Singh K . Glaucoma Suspect: Diagnosis and Management. Asia Pac J Ophthalmol (Phila). 2016; 5(1):32-7. DOI: 10.1097/APO.0000000000000173. View

Medeiros F, Weinreb R, Sample P, Gomi C, Bowd C, Crowston J . Validation of a predictive model to estimate the risk of conversion from ocular hypertension to glaucoma. Arch Ophthalmol. 2005; 123(10):1351-60. DOI: 10.1001/archopht.123.10.1351. View

Bowd C, Lee I, Goldbaum M, Balasubramanian M, Medeiros F, Zangwill L . Predicting glaucomatous progression in glaucoma suspect eyes using relevance vector machine classifiers for combined structural and functional measurements. Invest Ophthalmol Vis Sci. 2012; 53(4):2382-9. PMC: 3760232. DOI: 10.1167/iovs.11-7951. View

Halawa O, Jin Q, Pasquale L, Kang J, Lorch A, Sobrin L . Race and Ethnicity Differences in Disease Severity and Visual Field Progression Among Glaucoma Patients. Am J Ophthalmol. 2022; 242:69-76. PMC: 9842097. DOI: 10.1016/j.ajo.2022.05.023. View

Gracitelli C, Zangwill L, Diniz-Filho A, Abe R, Girkin C, Weinreb R . Detection of Glaucoma Progression in Individuals of African Descent Compared With Those of European Descent. JAMA Ophthalmol. 2018; 136(4):329-335. PMC: 5876834. DOI: 10.1001/jamaophthalmol.2017.6836. View

Patrick M, Wightman P, Schoeni R, Schulenberg J . Socioeconomic status and substance use among young adults: a comparison across constructs and drugs. J Stud Alcohol Drugs. 2012; 73(5):772-82. PMC: 3410945. DOI: 10.15288/jsad.2012.73.772. View

10.

Fraser S, Bunce C, Wormald R . Retrospective analysis of risk factors for late presentation of chronic glaucoma. Br J Ophthalmol. 1999; 83(1):24-8. PMC: 1722771. DOI: 10.1136/bjo.83.1.24. View

11.

Tehrani S . Gender difference in the pathophysiology and treatment of glaucoma. Curr Eye Res. 2014; 40(2):191-200. DOI: 10.3109/02713683.2014.968935. View

12.

Mohammadzadeh V, Moghimi S, Nishida T, Walker E, Kamalipour A, Micheletti E . Association of Rates of Ganglion Cell and Inner Plexiform Thinning With Development of Glaucoma in Eyes With Suspected Glaucoma. JAMA Ophthalmol. 2023; 141(4):349-356. PMC: 9982742. DOI: 10.1001/jamaophthalmol.2023.0005. View

13.

Kaplan R, Chambers D, Glasgow R . Big data and large sample size: a cautionary note on the potential for bias. Clin Transl Sci. 2014; 7(4):342-6. PMC: 5439816. DOI: 10.1111/cts.12178. View

14.

Salvetat M, Zeppieri M, Tosoni C, Brusini P . Baseline factors predicting the risk of conversion from ocular hypertension to primary open-angle glaucoma during a 10-year follow-up. Eye (Lond). 2016; 30(6):784-95. PMC: 4906466. DOI: 10.1038/eye.2016.86. View

15.

Coleman A, Miglior S . Risk factors for glaucoma onset and progression. Surv Ophthalmol. 2008; 53 Suppl1:S3-10. DOI: 10.1016/j.survophthal.2008.08.006. View

16.

Qassim A, Mullany S, Abedi F, Marshall H, Hassall M, Kolovos A . Corneal Stiffness Parameters Are Predictive of Structural and Functional Progression in Glaucoma Suspect Eyes. Ophthalmology. 2020; 128(7):993-1004. DOI: 10.1016/j.ophtha.2020.11.021. View

17.

KhalafAllah M, Zangwill L, Proudfoot J, Walker E, Girkin C, Fazio M . Racial Differences in Diagnostic Accuracy of Retinal Nerve Fiber Layer Thickness in Primary Open-Angle Glaucoma. Am J Ophthalmol. 2024; 259:7-14. PMC: 11068369. DOI: 10.1016/j.ajo.2023.10.012. View

18.

Bommakanti N, De Moraes C, Boland M, Myers J, Wellik S, Elze T . Baseline Age and Mean Deviation Affect the Rate of Glaucomatous Vision Loss. J Glaucoma. 2019; 29(1):31-38. DOI: 10.1097/IJG.0000000000001401. View

19.

Melchior B, Valenzuela I, De Moraes C, Paula J, Fazio M, Girkin C . Glaucomatous Visual Field Progression in the African Descent and Glaucoma Evaluation Study (ADAGES): Eleven Years of Follow-up. Am J Ophthalmol. 2022; 239:122-129. PMC: 9233143. DOI: 10.1016/j.ajo.2022.02.003. View

20.

Mwanza J, Tulenko S, Barton K, Herndon L, Mathenge E, Hall A . Eight-Year Incidence of Open-Angle Glaucoma in the Tema Eye Survey. Ophthalmology. 2018; 126(3):372-380. DOI: 10.1016/j.ophtha.2018.10.016. View